Insider Trading May 5, 2026 07:28 PM

Major Stakeholder Discovery Capital Reduces Position in Ramaco Resources via Large Stock Sale

A 10% owner liquidates $2.96 million in METC shares amid corporate restructuring and recent financial reporting.

By Marcus Reed METC

Discovery Capital Management, LLC, a significant institutional participant in Ramaco Resources, Inc. (NASDAQ:METC), has executed a notable reduction in its equity holdings. On May 1, 2026, the firm reported the sale of 200,000 shares of Class A Common Stock, a transaction valued at approximately $2,958,000. The divestment occurred at a price point of $14.79 per share, which sits slightly below the prevailing market price of $15.02. This transaction comes as the company navigates various strategic shifts, including a planned corporate reorganization and recent financial disclosures.

Major Stakeholder Discovery Capital Reduces Position in Ramaco Resources via Large Stock Sale
METC

Key Points

  • Discovery Capital Management reduced its position in METC by selling 200,000 shares for $2.96 million.
  • Ramaco Resources is undergoing a corporate reorganization into four distinct wholly owned subsidiaries.
  • Goldman Sachs upgraded the stock rating from Sell to Neutral with a $15.00 target.

Discovery Capital Management, LLC, acting in its capacity as an investment manager alongside managing member Robert K. Citrone, has reduced its beneficial ownership of Ramaco Resources, Inc. (METC). The transaction involved the sale of 200,000 shares of Class A Common Stock on May 1, 2026, totaling $2,958,000 at a price of $14.79 per share.

The entity associated with this transaction, Discovery Global Opportunity Master Fund, Ltd., remains a 10% owner of the company. Following this specific disposal, the fund retains a substantial holding of 5,311,360 shares in Ramaco Resources. This movement follows a period of notable price fluctuation for METC, which has seen its share value swing between $8.21 and $57.80 over a 52-week trailing period. Valuation assessments suggest the stock may be trading at levels above its calculated fair value.


Key Market Developments

The recent activity at Ramaco Resources is characterized by several intersecting corporate events:

  • Institutional Divestment: The sale of nearly $3 million in equity by a 10% owner marks a significant movement in the company's ownership structure.
  • Strategic Reorganization: The company’s board has sanctioned a plan to reorganize into four separate divisions, each structured as a wholly owned subsidiary, to better align with specific business operations.
  • Financial Performance and Analyst Adjustments: While Q4 2025 results showed an earnings per share loss, the company highlighted improved financial positioning through cost reduction and proprietary technology. Concurrently, Goldman Sachs moved its rating from Sell to Neutral, setting a $15.00 price target based on valuation metrics.

These developments impact the broader energy and natural resources sectors, as changes in ownership and corporate structure can signal shifts in how large-scale commodity producers manage capital and operational focus.


Risks and Uncertainties

Investors monitoring Ramaco Resources face several specific areas of uncertainty mentioned in recent filings:

  • Legal and Intellectual Property Risks: The company is currently engaged in a trade secrets lawsuit against former employee Alex J. Moyes, alleging breach of contract and misappropriation of proprietary information.
  • Market Volatility: The wide trading range of $8.21 to $57.80 over the last year highlights significant volatility within the stock.
  • Valuation Discrepancies: Current market pricing sits at a level that some analyses identify as overvalued relative to fair value calculations.

Such risks can influence investor sentiment across the industrial and resource-based markets, particularly regarding the stability of proprietary operational advantages.


Executive Activity

In addition to institutional selling, internal stock movements were noted via CEO Randall W. Atkins, who exercised options from a 2017 public offering to acquire shares of both Class A and Class B stock. These actions, combined with the aforementioned reorganization and legal proceedings, present a complex landscape for stakeholders evaluating the company's current trajectory.

Risks

  • Legal uncertainty stemming from a trade secrets lawsuit against a former employee.
  • Potential overvaluation of the stock based on fair value calculations.
  • Significant historical price volatility within the 52-week period.

More from Insider Trading

SentinelOne CEO Executes $3.55 Million Stock Sale Under Rule 10b5-1 Plan May 5, 2026 Axsome Therapeutics COO Executes $1.08 Million Stock Sale via Pre-Planned Trading Program May 5, 2026 Arcutis Biotherapeutics Director Executes Stock Sale via Pre-Arranged Plan May 5, 2026 Amgen Executive Nancy Grygiel Executes Recent Stock Transactions May 5, 2026 Privia Health CFO Executes Stock Sales Totaling Over $200,000 via Rule 10b5-1 Plan May 5, 2026